313 related articles for article (PubMed ID: 11226303)
1. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
2. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
5. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
Kirchhof P; Fabritz L; Kilić A; Begrow F; Breithardt G; Kuhn M
J Mol Cell Cardiol; 2004 May; 36(5):691-700. PubMed ID: 15135664
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
Kuhn M
Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
[TBL] [Abstract][Full Text] [Related]
9. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
[TBL] [Abstract][Full Text] [Related]
10. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
11. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
Christoffersen C; Bartels ED; Nielsen LB
Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
[TBL] [Abstract][Full Text] [Related]
12. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
Lopez MJ; Wong SK; Kishimoto I; Dubois S; Mach V; Friesen J; Garbers DL; Beuve A
Nature; 1995 Nov; 378(6552):65-8. PubMed ID: 7477288
[TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
14. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice.
Sangaralingham SJ; Tse MY; Pang SC
J Endocrinol; 2007 Jul; 194(1):143-52. PubMed ID: 17592028
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
Ogawa Y; Tamura N; Chusho H; Nakao K
Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression.
Magga J; Vuolteenaho O; Tokola H; Marttila M; Ruskoaho H
Ann Med; 1998 Aug; 30 Suppl 1():39-45. PubMed ID: 9800882
[TBL] [Abstract][Full Text] [Related]
17. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A.
Kuhn M
Circ Res; 2003 Oct; 93(8):700-9. PubMed ID: 14563709
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular significance of the natriuretic peptide receptor, guanylyl cyclase-A, from studies using genetically engineered mice].
Kishimoto I
Nihon Rinsho; 2004 Sep; 62 Suppl 9():38-42. PubMed ID: 15506333
[No Abstract] [Full Text] [Related]
19. C-type natriuretic peptide and guanylyl cyclase B receptor.
Schulz S
Peptides; 2005 Jun; 26(6):1024-34. PubMed ID: 15911070
[TBL] [Abstract][Full Text] [Related]
20. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
Steinmetz M; Potthast R; Sabrane K; Kuhn M
Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
